Managing Director, CEO | NewPeak Metals Ltd.
Level 27, 111 Eagle Street, QLD 4000 Brisbane (AU)
+61 7 3303 0650
May 19th, 2021
New Peak Metals from Australia is pursuing a promising approach around precious and industrial metals. The Company is developing several projects on different continents and is fully committed to growth - their goal: to achieve great things with as few resources as possible. David Mason, Managing Director and CEO of NewPeak Metals, explains in an interview what the Company plans to do in 2021, why the Cachi project in Argentina is a sleeping giant and what role the share package of an Australian energy company can play in the long term.
President and CEO | Osino Resources Corp.
Suite 810 – 789 West Pender Street, V6C 1H2 Vancouver (CAN)
May 3rd, 2021
Osino Resources is exploring for gold in Namibia. The Twin Hills project has 1.9 million ounces of the precious metal and moves toward production in leaps and bounds. By the end of the year, the Company should have a feasibility study that will convince investors. The chances of this happening are good. Once before, Osino's team around serial founder and mining specialist Heye Daun successfully developed a gold project in Namibia and sold it to B2Gold. CEO Heye Daun explains in an interview where Osino's promising Twin Hills project stands today compared to the Otjikoto mine and why major investors like Ross Beaty are relaxed about their Osino shares.
President, CEO and Director | Scottie Resources Corp.
905 - 1111 West Hastings Street, V6E 2J3 Vancouver (CAN)
April 27th, 2021
Scottie Resources is developing a historic deposit in the Golden Triangle in the Canadian province of British Columbia. Conditions around the Scottie mine, which was already in production at low triple-digit gold prices, are steadily improving: ice is receding and exposing new rock layers. There has been heavy investment around the site in recent years. In the interview, Scottie CEO Brad Rourke talks about the drilling plans for 2021, the growing interest of large players in companies in the Golden Triangle, and explains why the planned acquisition of AUX Resources is a gamechanger for all shareholders.
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)
+65 6327 8971
April 20th, 2021
The Indonesian nickel producer Silkroad Nickel mines scarce industrial metals such as nickel and cobalt and processes them further in its own facilities. In addition to fixed supply agreements with the Chinese Company Tsingshan, the world's largest stainless steel producer, Silkroad is also investing in a processing plant together with Chinese partners to be able to produce basic materials for the battery industry, among other things. In an interview, Corporate Development Executive Jerre Foo explains the role of Silkroad Nickel's unique raw material mix, what distinguishes Indonesia as a mining region, the status of ESG criteria, and what role the new rotary kiln (RKEF) can play from 2022.
Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)
+49 621 490 817 0
Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."
April 12th, 2021
Deutsche Rohstoff AG has been investing in promising raw material projects worldwide since 2006. Over the years, the Mannheim-based Company has built up a wealth of expertise and an extensive network. Currently, the Company generates 100% of its sales from oil production in the USA. In addition, there are investments in copper, tungsten and gold. In particular, the share package in Almonty Industries, a company bringing one of the largest tungsten mines outside of China into production, should bring shareholders stable returns in the long term. In an interview, CEO Dr. Thomas Gutschlag talks about supply shortages of raw materials, the German industry's response to them, and where the Company can envisage making acquisitions.
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)
April 6th, 2021
The Canadian commodity developer Silver Viper searches for precious metals in Mexico and has a special focus on silver. Recently, the share attracted the growing interest of the market: The reason: Positive drill results and a latent takeover fantasy. In this interview, Steve Cope, President, CEO and Director of Silver Viper, talks about Mexico as a mining region, potential share price drivers and well-intentioned advice from the mining community to management.
CEO | Marble Financial
1200-1166 Alberni Street, V6E 3Z3 Vancouver (CAN)
March 31st, 2021
While the traditional financial industry is looking for growth, Marble Financial has found an attractive niche for itself: Thanks to artificial intelligence, the fintech is bringing people with bad credit back into the financial system - and gaining a valuable treasure trove of data along the way. In this interview, Marble CEO Karim Nanji explains how you can earn money with people with bad credit, what products his Company offers, what is important for the Company as it expands into the US, and how Marble plans to increase its sales tenfold by 2023.
March 29th, 2021
Even before Elon Musk's Company SpaceX came on the scene, it was clear - there is good business to be made in space. Kleos Space, which has offices in the US, UK and Luxembourg, uses satellites to monitor radio frequency transmissions. Thanks to sophisticated technology and the intelligent combination of the collected data, authorities, states or companies can profit from their services. Kleos Space CEO Andy Bowyer explains how the business model works, why customers value the exchange with Kleos Space and why summer 2021 is set to be a milestone for the Company.
CEO | Cardiol Therapeutics
602-2265 Upper Middle Road East, L6H 0G5 Oakville (CAN)
+1 (289) 910-0850
Interview with Cardiol Therapeutics: How the heart disease specialist company plans to take off on the Nasdaq in 2021
March 26th, 2021
Cardiol Therapeutics is a biotechnology company that has declared war on potentially lethal inflammatory processes in the heart. To do this, the Company relies on the extensively researched active ingredient cannabidiol (CBD) which has been shown to reduce inflammation in a number of pre-clinical tests that have formed the basis for the Company’s Phase II/III clinical programs. The Company obtains the active ingredient synthetically and is currently researching various areas of application and forms of administration for its proprietary CBD formulation CardiolRx™. With the Company’s commercial CBD oral formulation, Cortalex™, Cardiol is already on the market with the purest CBD oil in the world and expects this product to generate major growth. Cardiol Therapeutics is now preparing to list on the Nasdaq which will position the Company to compete with the very big players in the biotech industry. In this interview, President and CEO David Elsley talks about CBD as an active ingredient, the research approach of Cardiol Therapeutics, the opportunities of the proposed Nasdaq listing for shareholders, and completely new ideas around innovative medicines. Leede Jones Gable analyst Douglas W. Loe yesterday rated the stock a 'Speculative Buy' with a price target of CAD 12.50 in an initial coverage report.
March 24th, 2021
Real estate, tourism and media - the field of activity of Singapore-based The Place Holdings is diverse. In this interview, Mr. Fan Xian Yong, CEO of The Place Holdings, explains how all three business areas complement each other, what innovations the company is pursuing, the role of strong partners in local markets, and why the company's cautious approach should pay off for shareholders.
CEO | PsyBio Therapeutics
4400 West Sample Rd, FL-33073 Coconut Creek (USA)
March 15th, 2021
The U.S. biotech company PsyBio is focusing on active ingredients to combat depression and other mental illnesses. To this end, it is conducting research around psilocybin, an active ingredient derived from so-called magic mushrooms, which the company can produce itself inexpensively thanks to specially developed and patented processes using bacteria. Co-founder and CEO Evan Levine is certain that these active ingredients have what it takes to revolutionize the market for psychotropic drugs and bring great benefits to patients.
Executive Chairman | Rock Tech Lithium Inc.
600 – 777 Hornby Street, V6Z 1S4 Vancouver (CAN)
March 8th, 2021
Rock Tech Lithium plans to supply the German automotive industry with lithium from 2023. The Company mines the battery metal sustainably in Canada according to Western standards and does so without wasting precious water or other negative environmental impacts. In further steps, the lithium will be refined for processing in battery factories, and the Company, owned by German Chairman Dirk Harbecke, will also rely on its own patents. Harbecke explains in an interview why it is a great advantage to map the entire value chain, why the market has not yet recognized the Company's potential, and what role prominent advocates play for Rock Tech Lithium.